Drugs Made In America Acquisition Corp.
- Last sale
- Nov 12, 2026
- Market cap
- $264.62M
- 24.28M shares
- Filings
- 81
—
—
—Q2 2026
—Q2 2026
——
—
—FY 2024
—Q2 2026+354.3% FY25 yoy
- $264.62M
- 44.5×
- —
- —
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
General And Administrative
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,816,013 | reported |
Blank check companies
Drugs Made In America Acquisition Corp. is the 140th largest of the 303 covered companies the SEC files under this code, by market cap. SIC 6770
CompanyRevenueGrowthNet marginMarket cap
MUZEMuzero Acquisition Corp———$273.7MNHIVNewHold Investment Corp IV———$273.6MDNMXDynamix Corp III———$269.4MSOULSoulpower Acquisition Corp.———$268.0MXTERXterax Corp II———$267.4MCATLCatalyst Acquisition Corp.———$266.0MOACCOaktree Acquisition Corp. III Life Sciences———$265.5M
DMAADrugs Made In America Acquisition Corp. (this company)———$264.6M
TRGSTRG Latin America Acquisitions Corp.———$259.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Drugs Made In America Acquisition Corp. · CIK 2028614 · Engraved from SEC EDGAR